425: CoreWeave Holds Firm on $9B Core Scientific Bid

CoreWeave CEO Michael Intrator stated the company will not revise its $9 billion acquisition bid for Core Scientific, despite investor objections.

Summary

• CoreWeave CEO Michael Intrator confirmed the company will not change its $9 billion bid for Core Scientific, asserting it fairly represents value.
• Core Scientific investor Two Seas Capital LP publicly objected to the deal, citing inadequate valuation, a deficient structure, and a flawed process.
• The merger is scheduled for a Core Scientific shareholder vote on October 30.
• CoreWeave expects to maintain a strong relationship with Core Scientific regardless of the acquisition's outcome.
• Core Scientific shares fell as much as 8.4% to $16.41 in New York after Intrator's remarks on October 7, 2025.
• The original takeover offer, announced in July, valued Core Scientific at $20.40 per share.
• CoreWeave aims to acquire approximately one gigawatt of data center capacity as part of the Core Scientific deal.
• CoreWeave's CEO described Core Scientific's contribution as a "small and shrinking part of our portfolio."
• The deal spread has remained negative for months, with CoreWeave's all-stock offer value consistently below Core Scientific's trading price, spurring market speculation for a sweetened deal.

Sentiment

Score: 3

Explanation: The sentiment is negative due to CoreWeave's firm stance on a bid deemed "lowball" by a major investor, the subsequent drop in Core Scientific's share price, and persistent market skepticism reflected in the negative deal spread. While CoreWeave expresses confidence, the immediate market reaction and investor opposition indicate significant headwinds for the deal as currently structured.

Positives

• CoreWeave aims to gain approximately one gigawatt of data center capacity, crucial for its AI-focused cloud computing operations.
• The companies already have an existing partnership, with Core Scientific delivering power to shared data centers, indicating operational familiarity.
• CoreWeave's CEO expressed a commitment to maintaining a "great relationship" with Core Scientific, regardless of the acquisition outcome, suggesting continued collaboration even if the merger fails.

Negatives

• CoreWeave's $9 billion bid is considered a "lowball offer" by a significant Core Scientific investor, Two Seas Capital LP.
• Two Seas Capital LP is voting against the deal and urged other shareholders to do the same, citing inadequate valuation, deficient structure, and a flawed process.
• Core Scientific's shares dropped by 8.4% to $16.41 following CoreWeave CEO's remarks, indicating a negative market reaction to the firm stance on the bid.
• The current trading price of Core Scientific ($16.41) is significantly below the original offer value ($20.40 per share), reflecting market skepticism about the deal's completion or terms.
• The deal spread has remained negative for months, with CoreWeave's all-stock offer value consistently below Core Scientific's trading price, which is rare for a large acquisition and suggests a lack of market confidence.

Risks

• Uncertainty regarding the completion of the proposed transaction on anticipated terms, or at all, and the timing of completion, including obtaining Core Scientific stockholder approval.
• Fluctuations in the market price of CoreWeave common stock could impact the value of consideration Core Scientific stockholders would receive.
• Potential for anticipated benefits (e.g., synergies, value creation) of the proposed transaction not to be realized or realized within the expected time period.
• Risks of potential litigation relating to the proposed transaction that could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.
• Disruptions from the proposed transaction harming CoreWeave's or Core Scientific's business, including current plans and operations, and diverting management's time and attention.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Rating agency actions and CoreWeave's and Core Scientific's ability to access shortand long-term debt markets on a timely and affordable basis.
• Legislative, regulatory, and economic developments and actions targeting public companies in the artificial intelligence, power, data center, and crypto mining industries.
• Potential business uncertainty, including the outcome of commercial negotiations and changes to existing business relationships during the pendency of the proposed transaction.
• Certain restrictions during the pendency of the proposed transaction that may impact Core Scientific's ability to pursue certain business opportunities or strategic transactions.
• Acts of terrorism or outbreak of war, hostilities, civil unrest, attacks against CoreWeave or Core Scientific, and other political or security disturbances.
• Dilution caused by CoreWeave's issuance of additional shares of its securities in connection with the proposed transaction.
• The possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events.
• The impacts of pandemics or other public health crises, including the effects of government responses on people and economies.
• Global or regional changes in the supply and demand for power and other market or economic conditions that impact demand and pricing.
• Changes in technical or operating conditions, including unforeseen technical difficulties.
• Development delays at CoreWeave and/or Core Scientific data center sites, including any delays in the conversion of such sites from crypto mining facilities to high-performance computing sites.

Future Outlook

CoreWeave will not readdress its $9 billion bid for Core Scientific, believing it fairly represents value. The merger is subject to a shareholder vote on October 30. CoreWeave anticipates maintaining a strong relationship with Core Scientific regardless of the acquisition's outcome, suggesting continued partnership even if the deal fails. However, market speculation suggests CoreWeave may need to sweeten the deal to gain shareholder support.

Management Comments

• "Really under no circumstances will we readdress the bid that we put out. That's the number. We think it fairly represents the value for them." Michael Intrator, CoreWeave CEO.
• "We think it will be great for the two companies to move forward together." Michael Intrator, CoreWeave CEO.
• "Regardless of the outcome of this acquisition, we will continue to have a great relationship with them." Michael Intrator, CoreWeave CEO.
• "This [Core Scientific's contribution] as a small and shrinking part of our portfolio." Michael Intrator, CoreWeave CEO.

Industry Context

The acquisition targets Core Scientific's data center capacity, which is valuable for CoreWeave's AI-focused cloud computing operations. This highlights the increasing demand for robust infrastructure to support the growing artificial intelligence sector. The potential conversion of crypto mining facilities to high-performance computing sites, as implied by CoreWeave's interest, is a notable trend in the data center industry, reflecting a strategic shift in resource allocation towards more profitable and high-demand computing services like AI.

Comparison to Industry Standards

• The negative deal spread, where CoreWeave's all-stock offer value remains below Core Scientific's trading price, is described as "rare for a big acquisition," suggesting it deviates from typical market expectations for successful takeovers.
• The market speculation that CoreWeave may need to "sweeten the deal offer" to gain shareholder support indicates that the current terms are not meeting industry expectations for a compelling acquisition premium, especially given the investor objections.

Legal Proceedings

• Potential litigation relating to the proposed transaction that could be instituted against CoreWeave, Core Scientific, or their respective directors and officers is identified as a risk factor.

Stakeholder Impact

• **Shareholders (Core Scientific):** Face uncertainty regarding the acquisition's completion and the value of the all-stock offer, which is currently below their trading price. A major investor is actively opposing the deal due to perceived inadequate valuation.
• **Shareholders (CoreWeave):** Potential dilution from the issuance of new shares for the acquisition.
• **Management (Core Scientific & CoreWeave):** Time and attention may be diverted to transaction-related issues due to the ongoing acquisition process and investor dissent.
• **Employees (Core Scientific & CoreWeave):** Potential disruptions to business, current plans, and operations are identified as a risk.
• **Customers/Partners:** The existing partnership between CoreWeave and Core Scientific is expected to continue, but the acquisition's outcome could influence future strategic alignments and service offerings.

Next Steps

• Core Scientific shareholders are scheduled to vote on the merger on October 30.
• CoreWeave and Core Scientific expect to continue their existing partnership regardless of the acquisition outcome.

Key Dates

Recommendation

The current bid is facing significant investor opposition and market skepticism, as evidenced by the negative deal spread and Core Scientific's share price drop. While CoreWeave is holding firm, the outcome of the October 30 shareholder vote is uncertain. Investors should hold to see if the deal proceeds as is, if CoreWeave is forced to sweeten the offer, or if the deal collapses, as each scenario carries different implications for valuation. The current offer is not compelling enough to 'buy' given the market's negative reaction, but the strategic value of Core Scientific's assets for AI infrastructure suggests it's not a 'sell' either, especially if a revised offer emerges.

Keywords

CoreWeave, Core Scientific, acquisition, merger, data center, AI, cloud computing, shareholder vote, M&A, SEC filing, cryptocurrency mining